首页 > 最新文献

Endocrine, metabolic & immune disorders drug targets最新文献

英文 中文
Mobilizing Stockpile of Nature: Phytochemicals, Herbal Extracts, and Dietary Supplements for Managing Metabolic Diseases with Concentric Focus on Obesity 调动自然储备:植物化学物质、草药提取物和膳食补充剂用于控制代谢性疾病,重点关注肥胖症
Pub Date : 2024-09-23 DOI: 10.2174/0118715303316634240822073810
Satyajit Mohanty, Nikita Nayak, Tuhin Mukherjee, Shivangi Kumari, Pranav Kumar Prabhakar, Ashok Pattnaik

Obesity and associated health impairments are proven to exhibit multifocal health disorders along with increasing co-morbidity. Underlying obesity pathology is linked up with almost every major disease, which may increase the risk of heart disease, hypertension, diabetes, cancer, osteoarthritis, etc. The prevalence of overweight and obesity is on the rise around the world, which enormously affects the life span of individuals. Due to the foggier nature of the underlying pathology, the efficacy is questionable for conventional treatments. The traditional therapy of obesity may involve synthetic moieties and surgical procedures, which have many harmful side effects and chances of recurrent severity. Scientists are continuously focusing on prophylactic remedies alongside maintaining a proper lifestyle. In that context, nature always helped with traditional medications. As per folklore medicine reports, many plants have been used to treat obesity and its associated complications. This review compiles a vast array of datasets, including the impact of obesity and the need for the introduction of phytochemicals in place of conventional pharmacotherapies, the impact of phytochemicals along with the reported mechanisms of action, recent clinical trial reports, and recently explored dietary supplements. The primary objective of this presentation is to chart the future trajectory of phytochemical research for metabolic disorders, establishing a foundational framework for future investigations to build upon.

事实证明,肥胖症和相关的健康损害表现出多重健康障碍,而且共病率越来越高。潜在的肥胖病理与几乎所有重大疾病都有关联,可能会增加患心脏病、高血压、糖尿病、癌症、骨关节炎等疾病的风险。超重和肥胖症的发病率在全球呈上升趋势,这极大地影响了个人的寿命。由于潜在病理的模糊性,传统疗法的疗效值得怀疑。肥胖症的传统疗法可能涉及合成药物和外科手术,但这些疗法有许多有害的副作用,而且有可能反复发作。科学家们在保持正确生活方式的同时,也在不断关注预防性疗法。在这方面,大自然总是会用传统药物来帮助人们。根据民间医药报告,许多植物都被用来治疗肥胖症及其相关并发症。本综述汇集了大量数据,包括肥胖症的影响、引入植物化学物质替代传统药物疗法的必要性、植物化学物质的影响以及所报告的作用机制、最新临床试验报告和最近探索的膳食补充剂。本报告的主要目的是描绘植物化学物研究在代谢紊乱方面的未来发展轨迹,为未来的研究建立一个基础框架。
{"title":"Mobilizing Stockpile of Nature: Phytochemicals, Herbal Extracts, and Dietary Supplements for Managing Metabolic Diseases with Concentric Focus on Obesity","authors":"Satyajit Mohanty, Nikita Nayak, Tuhin Mukherjee, Shivangi Kumari, Pranav Kumar Prabhakar, Ashok Pattnaik","doi":"10.2174/0118715303316634240822073810","DOIUrl":"https://doi.org/10.2174/0118715303316634240822073810","url":null,"abstract":"<p><p>Obesity and associated health impairments are proven to exhibit multifocal health disorders along with increasing co-morbidity. Underlying obesity pathology is linked up with almost every major disease, which may increase the risk of heart disease, hypertension, diabetes, cancer, osteoarthritis, etc. The prevalence of overweight and obesity is on the rise around the world, which enormously affects the life span of individuals. Due to the foggier nature of the underlying pathology, the efficacy is questionable for conventional treatments. The traditional therapy of obesity may involve synthetic moieties and surgical procedures, which have many harmful side effects and chances of recurrent severity. Scientists are continuously focusing on prophylactic remedies alongside maintaining a proper lifestyle. In that context, nature always helped with traditional medications. As per folklore medicine reports, many plants have been used to treat obesity and its associated complications. This review compiles a vast array of datasets, including the impact of obesity and the need for the introduction of phytochemicals in place of conventional pharmacotherapies, the impact of phytochemicals along with the reported mechanisms of action, recent clinical trial reports, and recently explored dietary supplements. The primary objective of this presentation is to chart the future trajectory of phytochemical research for metabolic disorders, establishing a foundational framework for future investigations to build upon.</p>","PeriodicalId":94316,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142335712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interpreting the Function of the IL-23/IL-17 Axis through Bioinformatics. 通过生物信息学解读 IL-23/IL-17 轴的功能。
Pub Date : 2024-09-23 DOI: 10.2174/0118715303316226240823045641
Sonia Isela Vázquez-Jiménez, Grecia Denisse González-Sánchez, Celia Guerrero-Velázquez, Juan Manuel Guzman-Flores

Introduction/objective: Bioinformatic analysis is a valuable tool that allows us to collect, archive, analyze, and disseminate biological data for further interpretation. Analysis of the IL-23/IL-17A axis and its receptors will provide us with essential information about their functions, interactions, and relationships with various diseases. This review aims to identify the central genes co-expressed in the IL-23/IL-17A axis and their receptors and to understand their ontology and modifying factors.

Methods: We used several databases, including COXPRESdb to obtain the co-expressed genes, ShinyGO and ToppGene platforms to explore gene functional enrichment, and the NetworkAnalyst 3.0 platform for gene expression profiling.

Results: We found that genes encoding IL-23/IL-17A axis proteins and their receptors mainly respond to microbial components, participate in the inflammatory response, and are primarily associated with inflammatory and autoimmune diseases. In addition, we observed an association of the IL-23/IL-17 axis with Behcet's disease, Graft-versus-host disease, and Hodgkin's disease, although there is no direct evidence of their interaction.

Conclusion: The IL-23/IL-17A axis is associated with several inflammatory and autoimmune pathologies. Therefore, we suggest further research to confirm its role in these pathologies and, if possible, use it as a therapeutic target.

引言/目的:生物信息分析是一种宝贵的工具,它使我们能够收集、归档、分析和传播生物数据,以便进一步解读。对 IL-23/IL-17A 轴及其受体的分析将为我们提供有关其功能、相互作用以及与各种疾病关系的重要信息。本综述旨在确定在 IL-23/IL-17A 轴及其受体中共同表达的中心基因,并了解其本体和修饰因素:我们使用了多个数据库,包括 COXPRESdb 来获取共表达基因,ShinyGO 和 ToppGene 平台来探索基因功能富集,以及 NetworkAnalyst 3.0 平台来进行基因表达谱分析:我们发现,编码IL-23/IL-17A轴蛋白及其受体的基因主要对微生物成分做出反应,参与炎症反应,并且主要与炎症和自身免疫性疾病相关。此外,我们还观察到IL-23/IL-17轴与白塞氏病、移植物抗宿主病和霍奇金病有关,但没有直接证据表明它们之间存在相互作用:结论:IL-23/IL-17A 轴与多种炎症和自身免疫性病症有关。结论:IL-23/IL-17A 轴与多种炎症和自身免疫性病症有关,因此,我们建议进一步研究以确认其在这些病症中的作用,并在可能的情况下将其作为治疗靶点。
{"title":"Interpreting the Function of the IL-23/IL-17 Axis through Bioinformatics.","authors":"Sonia Isela Vázquez-Jiménez, Grecia Denisse González-Sánchez, Celia Guerrero-Velázquez, Juan Manuel Guzman-Flores","doi":"10.2174/0118715303316226240823045641","DOIUrl":"https://doi.org/10.2174/0118715303316226240823045641","url":null,"abstract":"<p><strong>Introduction/objective: </strong>Bioinformatic analysis is a valuable tool that allows us to collect, archive, analyze, and disseminate biological data for further interpretation. Analysis of the IL-23/IL-17A axis and its receptors will provide us with essential information about their functions, interactions, and relationships with various diseases. This review aims to identify the central genes co-expressed in the IL-23/IL-17A axis and their receptors and to understand their ontology and modifying factors.</p><p><strong>Methods: </strong>We used several databases, including COXPRESdb to obtain the co-expressed genes, ShinyGO and ToppGene platforms to explore gene functional enrichment, and the NetworkAnalyst 3.0 platform for gene expression profiling.</p><p><strong>Results: </strong>We found that genes encoding IL-23/IL-17A axis proteins and their receptors mainly respond to microbial components, participate in the inflammatory response, and are primarily associated with inflammatory and autoimmune diseases. In addition, we observed an association of the IL-23/IL-17 axis with Behcet's disease, Graft-versus-host disease, and Hodgkin's disease, although there is no direct evidence of their interaction.</p><p><strong>Conclusion: </strong>The IL-23/IL-17A axis is associated with several inflammatory and autoimmune pathologies. Therefore, we suggest further research to confirm its role in these pathologies and, if possible, use it as a therapeutic target.</p>","PeriodicalId":94316,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142335708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ameliorative Effect of Herbal Medicine in the Management of Hepatotoxicity. 中草药在治疗肝中毒中的改善作用
Pub Date : 2024-09-23 DOI: 10.2174/0118715303319815240819053924
Sucharita Babu, Santosh K Ranjit, Gurudutta Pattnaik, Goutam Ghosh, Goutam Rath, Biswakanth Kar

Reactive oxygen species production, inflammation, an elevated serum profile, mitochondrial dysfunction, and up-regulation of proapoptotic mediators are the main mechanisms underlying chemotherapy-related hepatotoxicity, which results in hepatocyte disorders such as hepatitis, steatohepatitis, and fibrosis. The article aims to examine a prospective herbal remedy and its bioactive ingredients in terms of its antioxidant, anti-inflammatory, and anti-apoptotic capabilities, which offer superior protection against liver damage during chemotherapy administration. Plants including Silybum marianun, Nelumbo nucifera, Phyllanthus amarus, Plumbago zeylanica, Glycyrrhiza glabra, Citrus limon, and Nigella sativa may have hepatoprotective properties, according to the author. Last but not least, this will give aspiring scientists new knowledge for natural-based development in mitigating liver damage caused by chemotherapy medications.

活性氧的产生、炎症、血清谱升高、线粒体功能障碍以及促凋亡介质的上调是化疗相关肝毒性的主要机制,化疗相关肝毒性会导致肝炎、脂肪性肝炎和肝纤维化等肝细胞疾病。本文旨在从抗氧化、抗炎和抗细胞凋亡能力的角度研究一种前瞻性草药疗法及其生物活性成分,从而为化疗期间的肝损伤提供卓越的保护。作者认为,包括水飞蓟,蓮花,白花蛇舌草,板蓝根,甘草,柠檬和黑麦草在内的植物可能具有保护肝脏的特性。最后但并非最不重要的一点是,这将为有抱负的科学家提供新的知识,帮助他们以自然为基础进行开发,减轻化疗药物对肝脏造成的损害。
{"title":"Ameliorative Effect of Herbal Medicine in the Management of Hepatotoxicity.","authors":"Sucharita Babu, Santosh K Ranjit, Gurudutta Pattnaik, Goutam Ghosh, Goutam Rath, Biswakanth Kar","doi":"10.2174/0118715303319815240819053924","DOIUrl":"https://doi.org/10.2174/0118715303319815240819053924","url":null,"abstract":"<p><p>Reactive oxygen species production, inflammation, an elevated serum profile, mitochondrial dysfunction, and up-regulation of proapoptotic mediators are the main mechanisms underlying chemotherapy-related hepatotoxicity, which results in hepatocyte disorders such as hepatitis, steatohepatitis, and fibrosis. The article aims to examine a prospective herbal remedy and its bioactive ingredients in terms of its antioxidant, anti-inflammatory, and anti-apoptotic capabilities, which offer superior protection against liver damage during chemotherapy administration. Plants including Silybum marianun, Nelumbo nucifera, Phyllanthus amarus, Plumbago zeylanica, Glycyrrhiza glabra, Citrus limon, and Nigella sativa may have hepatoprotective properties, according to the author. Last but not least, this will give aspiring scientists new knowledge for natural-based development in mitigating liver damage caused by chemotherapy medications.</p>","PeriodicalId":94316,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142335705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Toluene-induced Infundibulo-neuro-hypophysitis: Presentation of a New Cause of Hypophysitis Secondary to Toxic Exposure and Review on Toluene Inhalation Endocrine Effects. 由甲苯诱发的肺泡神经性肾上腺皮质炎:继发于毒性暴露的肾上腺皮质炎新病因介绍及甲苯吸入对内分泌影响的综述。
Pub Date : 2024-09-23 DOI: 10.2174/0118715303306378240816104619
Flavia Costanza, Antonella Giampietro, Tommaso Tartaglione, Flavia Angelini, Simona Gaudino, Laura De Marinis, Alfredo Pontecorvi, Sabrina Chiloiro, Antonio Bianchi

Introduction: Hypophysitis is a rare inflammatory disorder of the pituitary gland. Symptoms and signs of hypophysitis can be various, progressing insidiously, and its recognition may be challenging.

Case presentation: We report the clinical history and therapeutic management of a 59-year-old man diagnosed with arginine vasopressin deficiency (AVP-D) due to an infundibulo-neurohypophysitis (INH) that occurred after the patient had inhaled spray film containing toluene. In consideration of the clinical signs and radiological imaging suggestive of INH, therapy with desmopressin and corticosteroids was instituted, with gradual improvement of polyuria and resolution of the radiological features of INH.

Conclusion: To our knowledge, we described the first case of INH, manifested with AVP-D, secondary to toluene exposure. In addition, the endocrine effects of toluene inhalation were discussed. Finally, given the scarcity of data available, an overview of all the known toxic substances inducing AVP-D was also provided.

简介垂体功能减退症是一种罕见的垂体炎症性疾病。垂体功能减退症的症状和体征多种多样,进展隐匿,其识别可能具有挑战性:我们报告了一名 59 岁男性患者的临床病史和治疗方法,该患者因吸入含甲苯的喷射膜后发生了肾小球下垂炎(INH),被诊断为精氨酸加压素缺乏症(AVP-D)。考虑到患者的临床症状和放射影像学检查均提示其患有 INH,医生开始使用去氨加压素和皮质类固醇进行治疗,患者的多尿症状逐渐得到改善,INH 的放射学特征也得到消除:据我们所知,我们描述了首例因接触甲苯而继发 INH 并伴有 AVP-D 的病例。此外,我们还讨论了吸入甲苯对内分泌的影响。最后,鉴于现有数据的稀缺性,我们还概述了所有已知的可诱发 AVP-D 的有毒物质。
{"title":"A Toluene-induced Infundibulo-neuro-hypophysitis: Presentation of a New Cause of Hypophysitis Secondary to Toxic Exposure and Review on Toluene Inhalation Endocrine Effects.","authors":"Flavia Costanza, Antonella Giampietro, Tommaso Tartaglione, Flavia Angelini, Simona Gaudino, Laura De Marinis, Alfredo Pontecorvi, Sabrina Chiloiro, Antonio Bianchi","doi":"10.2174/0118715303306378240816104619","DOIUrl":"https://doi.org/10.2174/0118715303306378240816104619","url":null,"abstract":"<p><strong>Introduction: </strong>Hypophysitis is a rare inflammatory disorder of the pituitary gland. Symptoms and signs of hypophysitis can be various, progressing insidiously, and its recognition may be challenging.</p><p><strong>Case presentation: </strong>We report the clinical history and therapeutic management of a 59-year-old man diagnosed with arginine vasopressin deficiency (AVP-D) due to an infundibulo-neurohypophysitis (INH) that occurred after the patient had inhaled spray film containing toluene. In consideration of the clinical signs and radiological imaging suggestive of INH, therapy with desmopressin and corticosteroids was instituted, with gradual improvement of polyuria and resolution of the radiological features of INH.</p><p><strong>Conclusion: </strong>To our knowledge, we described the first case of INH, manifested with AVP-D, secondary to toluene exposure. In addition, the endocrine effects of toluene inhalation were discussed. Finally, given the scarcity of data available, an overview of all the known toxic substances inducing AVP-D was also provided.</p>","PeriodicalId":94316,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142335704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anticancer Potential of Quercetin, Epigallocatechin Gallate, Kaempferol, Apigenin, and Curcumin against Several Human Carcinomas. 槲皮素、表没食子儿茶素没食子酸酯、堪非罗、芹菜素和姜黄素对几种人类癌症的抗癌潜力
Pub Date : 2024-09-23 DOI: 10.2174/0118715303320523240910072723
Megha Singh, Meenakshi Verma, Shivam Pandey, Rahul Kumar, Fahad Khan, Pratibha Pandey

Cancer remains a global health problem that requires constant research for the development of new treatment strategies. Flavonoids, a diverse group of naturally occurring polyphenolic compounds abundant in fruits, vegetables, and other plant sources, have received considerable attention for their potential anticancer properties. This review aimed to provide a comprehensive overview of the current scientific literature on five specific natural flavonoids, namely quercetin, Epigallocatechin Gallate (EGCG), kaempferol, apigenin, and curcumin that have been widely reported in numerous carcinomas and evaluate their effectiveness and mechanisms in fighting different types of cancer. Known for its antioxidant and anti-inflammatory properties, quercetin has shown promise in inhibiting cancer cells and modulating key signaling pathways. EGCG, a prominent catechin found in green tea, has been extensively studied for its ability to induce apoptosis and inhibit angiogenesis, highlighting its potential as an anticancer agent. Kaempferol has antioxidant and anti-inflammatory effects and has shown anticancer potential by modulating cellular processes involved in tumor development. Apigenin, abundant in parsley and chamomile, has been shown to exert anticancer properties by interrupting the cell cycle and inducing apoptosis in cancer cells. Curcumin has shown several anticancer effects, including inhibiting cell proliferation, inducing apoptosis, and modulating inflammatory pathways. Despite these promising findings, it is essential to recognize the complexity of cancer biology and the need for further research to clarify the precise mechanisms of action of these natural flavonoids and optimize their therapeutic applications. Furthermore, understanding flavonoids' potential synergy and interactions with traditional cancer therapies is paramount for developing effective combinatorial strategies. This review thus aimed to summarize the current knowledge on these natural flavonoids and provide insight into their potential role as an adjunctive or stand-alone therapy in the fight against breast, prostate, colon, lung, skin, ovarian, liver, and pancreatic cancer.

癌症仍然是一个全球性的健康问题,需要不断研究以开发新的治疗策略。类黄酮是一类天然存在的多酚化合物,在水果、蔬菜和其他植物中含量丰富,因其潜在的抗癌特性而受到广泛关注。本综述旨在全面综述目前有关五种特定天然类黄酮的科学文献,即槲皮素、表没食子儿茶素没食子酸酯(EGCG)、山奈酚、芹菜素和姜黄素,这些类黄酮已在多种癌症中被广泛报道,并评估它们在不同类型癌症中的抗癌效果和机制。槲皮素因其抗氧化和抗炎特性而闻名,它在抑制癌细胞和调节关键信号通路方面表现出良好的前景。EGCG 是绿茶中的一种主要儿茶素,它能够诱导细胞凋亡和抑制血管生成,已被广泛研究,凸显了其作为抗癌剂的潜力。山奈酚具有抗氧化和消炎作用,并通过调节肿瘤发生的细胞过程显示出抗癌潜力。芹菜素(Apigenin)在欧芹和洋甘菊中含量丰富,已被证明可通过中断细胞周期和诱导癌细胞凋亡来发挥抗癌作用。姜黄素具有多种抗癌作用,包括抑制细胞增殖、诱导细胞凋亡和调节炎症途径。尽管这些研究结果很有希望,但我们必须认识到癌症生物学的复杂性,并认识到有必要开展进一步的研究,以阐明这些天然类黄酮的确切作用机制,并优化其治疗应用。此外,了解类黄酮与传统癌症疗法的潜在协同作用和相互作用对于开发有效的组合策略至关重要。因此,本综述旨在总结目前有关这些天然类黄酮的知识,并深入探讨它们在对抗乳腺癌、前列腺癌、结肠癌、肺癌、皮肤癌、卵巢癌、肝癌和胰腺癌中作为辅助疗法或独立疗法的潜在作用。
{"title":"Anticancer Potential of Quercetin, Epigallocatechin Gallate, Kaempferol, Apigenin, and Curcumin against Several Human Carcinomas.","authors":"Megha Singh, Meenakshi Verma, Shivam Pandey, Rahul Kumar, Fahad Khan, Pratibha Pandey","doi":"10.2174/0118715303320523240910072723","DOIUrl":"https://doi.org/10.2174/0118715303320523240910072723","url":null,"abstract":"<p><p>Cancer remains a global health problem that requires constant research for the development of new treatment strategies. Flavonoids, a diverse group of naturally occurring polyphenolic compounds abundant in fruits, vegetables, and other plant sources, have received considerable attention for their potential anticancer properties. This review aimed to provide a comprehensive overview of the current scientific literature on five specific natural flavonoids, namely quercetin, Epigallocatechin Gallate (EGCG), kaempferol, apigenin, and curcumin that have been widely reported in numerous carcinomas and evaluate their effectiveness and mechanisms in fighting different types of cancer. Known for its antioxidant and anti-inflammatory properties, quercetin has shown promise in inhibiting cancer cells and modulating key signaling pathways. EGCG, a prominent catechin found in green tea, has been extensively studied for its ability to induce apoptosis and inhibit angiogenesis, highlighting its potential as an anticancer agent. Kaempferol has antioxidant and anti-inflammatory effects and has shown anticancer potential by modulating cellular processes involved in tumor development. Apigenin, abundant in parsley and chamomile, has been shown to exert anticancer properties by interrupting the cell cycle and inducing apoptosis in cancer cells. Curcumin has shown several anticancer effects, including inhibiting cell proliferation, inducing apoptosis, and modulating inflammatory pathways. Despite these promising findings, it is essential to recognize the complexity of cancer biology and the need for further research to clarify the precise mechanisms of action of these natural flavonoids and optimize their therapeutic applications. Furthermore, understanding flavonoids' potential synergy and interactions with traditional cancer therapies is paramount for developing effective combinatorial strategies. This review thus aimed to summarize the current knowledge on these natural flavonoids and provide insight into their potential role as an adjunctive or stand-alone therapy in the fight against breast, prostate, colon, lung, skin, ovarian, liver, and pancreatic cancer.</p>","PeriodicalId":94316,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142335706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Likelihood of Laryngeal Involvement in Autoimmune Thyroid Disorder Patients: A Meta-Analysis. 自身免疫性甲状腺疾病患者喉部受累的可能性:一项元分析
Pub Date : 2024-09-23 DOI: 10.2174/0118715303304858240904042316
Chuan Yue, Li Gu, Wei Guo

Background: The involvement of the larynx in many situations can have a substantial impact on a person's voice, breathing, and general health. Individuals with autoimmune thyroid disorders can experience a variety of conditions affecting the larynx. Autoimmune thyroid disorders, such as Hashimoto's thyroiditis [HT] and Graves' disease [GD], are prevalent conditions affecting the thyroid gland. Beyond their established impact on thyroid function, these disorders have been associated with laryngeal involvement. The current study aims to explore the likelihood of laryngeal involvement in patients with Autoimmune Thyroid Disorders [AITD].

Method: This study involved a retrospective analysis of medical records from patients diagnosed with autoimmune thyroid disorders. Inclusion criteria were a confirmed diagnosis through laboratory investigations and clinical assessment. Patients with pre-existing laryngeal pathologies or other conditions affecting the larynx were not considered. We collected data from 4 research articles and 3 clinical trials from Embase, PubMed, and NCBI-Trials portals, focusing on reported laryngeal symptoms. The severity of laryngeal involvement was assessed and categorized based on its extent and impact on vocal function.

Results: Preliminary analysis of the collected data indicated a significant proportion of patients with autoimmune thyroid disorders reporting laryngeal symptoms. Among these patients, various manifestations of laryngeal involvement were observed, including vocal changes, hoarseness, and throat discomfort.

Conclusion: The findings show that laryngeal symptoms may be an underappreciated feature of these diseases, potentially impacting vocal function and quality of life in affected people. Further research is also needed for more precise projections in this direction.

背景:喉部在很多情况下都会受到影响,这对人的嗓音、呼吸和全身健康都会产生重大影响。自身免疫性甲状腺疾病患者的喉部会受到多种疾病的影响。桥本氏甲状腺炎(HT)和巴塞杜氏病(GD)等自身免疫性甲状腺疾病是影响甲状腺的常见疾病。除了对甲状腺功能的既定影响外,这些疾病还与喉部受累有关。本研究旨在探讨自身免疫性甲状腺疾病(AITD)患者喉部受累的可能性:本研究对确诊为自身免疫性甲状腺疾病患者的病历进行了回顾性分析。纳入标准是通过实验室检查和临床评估确诊。已存在喉部病变或其他影响喉部疾病的患者不在考虑之列。我们从Embase、PubMed和NCBI-Trials门户网站的4篇研究文章和3项临床试验中收集了数据,重点关注报告的喉部症状。我们根据喉部受累的程度和对发声功能的影响对喉部受累的严重程度进行了评估和分类:对所收集数据的初步分析表明,有相当一部分自身免疫性甲状腺疾病患者报告了喉部症状。在这些患者中,观察到喉部受累的各种表现,包括发声改变、声音嘶哑和喉部不适:研究结果表明,喉部症状可能是这些疾病的一个未被重视的特征,可能会影响患者的发声功能和生活质量。还需要进一步研究,以便对此做出更精确的预测。
{"title":"Likelihood of Laryngeal Involvement in Autoimmune Thyroid Disorder Patients: A Meta-Analysis.","authors":"Chuan Yue, Li Gu, Wei Guo","doi":"10.2174/0118715303304858240904042316","DOIUrl":"https://doi.org/10.2174/0118715303304858240904042316","url":null,"abstract":"<p><strong>Background: </strong>The involvement of the larynx in many situations can have a substantial impact on a person's voice, breathing, and general health. Individuals with autoimmune thyroid disorders can experience a variety of conditions affecting the larynx. Autoimmune thyroid disorders, such as Hashimoto's thyroiditis [HT] and Graves' disease [GD], are prevalent conditions affecting the thyroid gland. Beyond their established impact on thyroid function, these disorders have been associated with laryngeal involvement. The current study aims to explore the likelihood of laryngeal involvement in patients with Autoimmune Thyroid Disorders [AITD].</p><p><strong>Method: </strong>This study involved a retrospective analysis of medical records from patients diagnosed with autoimmune thyroid disorders. Inclusion criteria were a confirmed diagnosis through laboratory investigations and clinical assessment. Patients with pre-existing laryngeal pathologies or other conditions affecting the larynx were not considered. We collected data from 4 research articles and 3 clinical trials from Embase, PubMed, and NCBI-Trials portals, focusing on reported laryngeal symptoms. The severity of laryngeal involvement was assessed and categorized based on its extent and impact on vocal function.</p><p><strong>Results: </strong>Preliminary analysis of the collected data indicated a significant proportion of patients with autoimmune thyroid disorders reporting laryngeal symptoms. Among these patients, various manifestations of laryngeal involvement were observed, including vocal changes, hoarseness, and throat discomfort.</p><p><strong>Conclusion: </strong>The findings show that laryngeal symptoms may be an underappreciated feature of these diseases, potentially impacting vocal function and quality of life in affected people. Further research is also needed for more precise projections in this direction.</p>","PeriodicalId":94316,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142335709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associative Learning in Subclinical Hypothyroidism at Different Ranges of Thyroid Stimulating Hormone: A Cambridge Neuropsychological Test Automated Battery (CANTAB) Study of Visual Paired Association Learning Task. 亚临床甲状腺功能减退症患者在不同促甲状腺激素水平下的联想学习:剑桥神经心理测试自动测试系统(CANTAB)视觉配对联想学习任务研究》。
Pub Date : 2024-09-23 DOI: 10.2174/0118715303312982240902102722
Satkarjit Kaur Jhandi, Shweta Shenoy, Ajaypal Singh

Background: Associative learning deficits are constantly found in subclinical hypothyroidism (SCH). Despite achieving normal thyroid stimulating hormone (TSH) levels, a considerable number of patients undergoing levothyroxine (LT-4) treatment frequently complain about memory retrieval. The Paired Association Learning (PAL) task involves computerised testing on the CANTAB- Cambridge Neuropsychological Test Automated Battery, also considered a screening tool for Alzheimer's disease (AD).

Purpose: This study aimed to investigate the impact of different levels of TSH on visual associative learning in SCH and determine if these impairments were reversed with LT-4.

Methods: A total of 134 participants were included in this cross-sectional study. Group 1: 35 healthy controls; patients with SCH (Group 2: 33 newly identified cases; Group 3: 32 patients on LT-4 with elevated TSH; Group 4: 34 euthyroid but on LT-4). A thyroid profile and a neuropsychological clinical assessment were done. The visual PAL task was performed on CANTAB.

Results: PAL was significantly impaired (p = <0.05) in all 3 patient groups as compared to Group 1. The PAL total errors (adjusted) scores were significantly higher in Groups 2 and 3, indicating that associative learning is definitely impaired in SCH, reaching levels previously seen in patients with AD.

Conclusion: Our findings encourage screening for visual associative learning or memory retrieval in patients with SCH. The study present has established a more reasonable threshold of TSH 2.5mIU/L to encourage examination of associative learning and the initiation of LT-4 in SCH. Poor PAL task performance in patients with SCH may have significant implications in clinical settings for suspecting AD.

背景:亚临床甲状腺功能减退症(SCH)患者经常出现联想学习障碍。尽管促甲状腺激素(TSH)水平正常,但相当多接受左甲状腺素(LT-4)治疗的患者经常抱怨记忆检索障碍。成对联想学习(PAL)任务涉及CANTAB-剑桥神经心理测试自动化电池的计算机化测试,也被视为阿尔茨海默病(AD)的筛查工具。目的:本研究旨在调查不同水平的促甲状腺激素对SCH患者视觉联想学习的影响,并确定LT-4是否能逆转这些障碍:这项横断面研究共纳入134名参与者。第一组:35名健康对照者;SCH患者(第二组:33名新发现病例;第三组:32名服用LT-4但TSH升高的患者;第四组:34名甲状腺功能正常但服用LT-4的患者)。他们接受了甲状腺检查和神经心理学临床评估。在CANTAB上进行视觉PAL任务:结果:视觉联想能力明显受损(p = 结论:我们的研究结果鼓励对视觉联想能力进行筛查:我们的研究结果鼓励对SCH患者进行视觉联想学习或记忆检索筛查。本研究确定了更为合理的阈值(TSH 2.5mIU/L),以鼓励对 SCH 患者进行联想学习检查并开始使用 LT-4。SCH患者的PAL任务表现不佳可能会对临床怀疑AD产生重大影响。
{"title":"Associative Learning in Subclinical Hypothyroidism at Different Ranges of Thyroid Stimulating Hormone: A Cambridge Neuropsychological Test Automated Battery (CANTAB) Study of Visual Paired Association Learning Task.","authors":"Satkarjit Kaur Jhandi, Shweta Shenoy, Ajaypal Singh","doi":"10.2174/0118715303312982240902102722","DOIUrl":"https://doi.org/10.2174/0118715303312982240902102722","url":null,"abstract":"<p><strong>Background: </strong>Associative learning deficits are constantly found in subclinical hypothyroidism (SCH). Despite achieving normal thyroid stimulating hormone (TSH) levels, a considerable number of patients undergoing levothyroxine (LT-4) treatment frequently complain about memory retrieval. The Paired Association Learning (PAL) task involves computerised testing on the CANTAB- Cambridge Neuropsychological Test Automated Battery, also considered a screening tool for Alzheimer's disease (AD).</p><p><strong>Purpose: </strong>This study aimed to investigate the impact of different levels of TSH on visual associative learning in SCH and determine if these impairments were reversed with LT-4.</p><p><strong>Methods: </strong>A total of 134 participants were included in this cross-sectional study. Group 1: 35 healthy controls; patients with SCH (Group 2: 33 newly identified cases; Group 3: 32 patients on LT-4 with elevated TSH; Group 4: 34 euthyroid but on LT-4). A thyroid profile and a neuropsychological clinical assessment were done. The visual PAL task was performed on CANTAB.</p><p><strong>Results: </strong>PAL was significantly impaired (p = <0.05) in all 3 patient groups as compared to Group 1. The PAL total errors (adjusted) scores were significantly higher in Groups 2 and 3, indicating that associative learning is definitely impaired in SCH, reaching levels previously seen in patients with AD.</p><p><strong>Conclusion: </strong>Our findings encourage screening for visual associative learning or memory retrieval in patients with SCH. The study present has established a more reasonable threshold of TSH 2.5mIU/L to encourage examination of associative learning and the initiation of LT-4 in SCH. Poor PAL task performance in patients with SCH may have significant implications in clinical settings for suspecting AD.</p>","PeriodicalId":94316,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142335707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of Acupuncture for Infertility in Patients with Polycystic Ovary Syndrome: A Systematic Review and Network Meta-Analysis. 针灸治疗多囊卵巢综合征患者不孕症的效果:系统回顾与网络荟萃分析》。
Pub Date : 2024-09-20 DOI: 10.2174/0118715303297819240826065755
Yumi Wu, QiWei Xiao, ShouDong Wang, HuanFang Xu, YiGong Fang

Objective: This study employs a network meta-analysis method to investigate the clinical effectiveness of acupuncture in patients with polycystic ovary syndrome (PCOS) experiencing infertility.

Methods: Prospective randomized controlled trials (RCTs) of clomiphene citrate (CC) and letrozole (LE) combined with acupuncture in PCOS infertility patients were identified through computerized searches in databases including PubMed, Web of Science, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang Data, and Chongqing VIP Database. The search period was set from inception until August 1, 2023, with no language restrictions. Two researchers screened articles, extracted data, and independently assessed the risk of bias in eligible trials. Data were analyzed and visualized using the R software gemtc package. With patients with medication treatment only set as controls, a meta-analysis was performed to investigate the difference in the pregnancy outcomes of the PCOS patients following medication amalgamated with different acupuncture treatments, namely, manual acupuncture (MA), electroacupuncture (EA), and warm acupuncture (WA).

Results: The serum concentrations of follicle-stimulating hormone (FSH) did not exhibit significant changes following acupuncture treatments. Notably, acupuncture-based medication treatment significantly reduced serum levels of luteinizing hormone (LH) and elevated the testosterone (T) concentrations of patients when compared to medication treatment alone. Patients also showed significantly escalated serum estradiol (E2) levels after receiving CC integrated with acupuncture than those given monotherapy of CC. The combined regimen of medication and acupuncture appeared to improve the pregnancy outcomes compared to the monotherapy of medication, as evidenced by the significantly increased success rate of pregnancy. Furthermore, the treatment combination of CC plus WA and LE plus MA yielded the highest probability of achieving the best pregnancy outcomes.

Conclusion: For PCOS infertility patients, acupuncture, as a complementary treatment to CC and LE, holds advantages in improving reproductive hormone levels and enhancing pregnancy success rates. The highest probability of achieving the best pregnancy outcomes is associated with the treatment combination of CC with WA and LE with MA.

目的:本研究采用网络荟萃分析法研究针灸对多囊卵巢综合征(PCOS)不孕症患者的临床疗效:本研究采用网络荟萃分析法研究针灸对多囊卵巢综合征(PCOS)不孕患者的临床疗效:方法:通过计算机检索PubMed、Web of Science、Embase、Cochrane图书馆、中国国家知识基础设施(CNKI)、万方数据和重庆VIP数据库等数据库,确定了枸橼酸氯米芬(CC)和来曲唑(LE)联合针灸治疗PCOS不孕患者的前瞻性随机对照试验(RCT)。检索期从开始到 2023 年 8 月 1 日,没有语言限制。两名研究人员筛选文章、提取数据,并独立评估合格试验的偏倚风险。数据使用 R 软件 gemtc 软件包进行分析和可视化。将仅接受药物治疗的患者设为对照组,进行荟萃分析,研究药物治疗与不同针灸疗法(即手针(MA)、电针(EA)和温针(WA))相结合后多囊卵巢综合征患者妊娠结局的差异:结果:针灸治疗后,促卵泡激素(FSH)的血清浓度没有发生显著变化。值得注意的是,与单纯药物治疗相比,针灸药物治疗可显著降低患者血清中黄体生成素(LH)的水平,并提高睾酮(T)的浓度。患者在接受 CC 联合针灸治疗后,血清雌二醇(E2)水平也明显高于单用 CC 治疗的患者。与单一药物治疗相比,药物和针灸联合疗法似乎能改善妊娠结局,这一点从妊娠成功率的显著提高中可见一斑。此外,CC加WA和LE加MA的治疗组合获得最佳妊娠结果的概率最高:结论:对于多囊卵巢综合征不孕症患者,针灸作为CC和LE的辅助治疗,在改善生殖激素水平和提高妊娠成功率方面具有优势。结论:对于多囊卵巢综合征不孕症患者,针灸作为CC和LE的辅助治疗,在改善生殖激素水平和提高妊娠成功率方面具有优势。
{"title":"Effectiveness of Acupuncture for Infertility in Patients with Polycystic Ovary Syndrome: A Systematic Review and Network Meta-Analysis.","authors":"Yumi Wu, QiWei Xiao, ShouDong Wang, HuanFang Xu, YiGong Fang","doi":"10.2174/0118715303297819240826065755","DOIUrl":"https://doi.org/10.2174/0118715303297819240826065755","url":null,"abstract":"<p><strong>Objective: </strong>This study employs a network meta-analysis method to investigate the clinical effectiveness of acupuncture in patients with polycystic ovary syndrome (PCOS) experiencing infertility.</p><p><strong>Methods: </strong>Prospective randomized controlled trials (RCTs) of clomiphene citrate (CC) and letrozole (LE) combined with acupuncture in PCOS infertility patients were identified through computerized searches in databases including PubMed, Web of Science, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang Data, and Chongqing VIP Database. The search period was set from inception until August 1, 2023, with no language restrictions. Two researchers screened articles, extracted data, and independently assessed the risk of bias in eligible trials. Data were analyzed and visualized using the R software gemtc package. With patients with medication treatment only set as controls, a meta-analysis was performed to investigate the difference in the pregnancy outcomes of the PCOS patients following medication amalgamated with different acupuncture treatments, namely, manual acupuncture (MA), electroacupuncture (EA), and warm acupuncture (WA).</p><p><strong>Results: </strong>The serum concentrations of follicle-stimulating hormone (FSH) did not exhibit significant changes following acupuncture treatments. Notably, acupuncture-based medication treatment significantly reduced serum levels of luteinizing hormone (LH) and elevated the testosterone (T) concentrations of patients when compared to medication treatment alone. Patients also showed significantly escalated serum estradiol (E2) levels after receiving CC integrated with acupuncture than those given monotherapy of CC. The combined regimen of medication and acupuncture appeared to improve the pregnancy outcomes compared to the monotherapy of medication, as evidenced by the significantly increased success rate of pregnancy. Furthermore, the treatment combination of CC plus WA and LE plus MA yielded the highest probability of achieving the best pregnancy outcomes.</p><p><strong>Conclusion: </strong>For PCOS infertility patients, acupuncture, as a complementary treatment to CC and LE, holds advantages in improving reproductive hormone levels and enhancing pregnancy success rates. The highest probability of achieving the best pregnancy outcomes is associated with the treatment combination of CC with WA and LE with MA.</p>","PeriodicalId":94316,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142309570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thyroid Hormone Resistance: A 17-Year Follow-up Case Report. 甲状腺激素抵抗:17 年随访病例报告
Pub Date : 2024-08-26 DOI: 10.2174/0118715303329834240815193640
Cristina Giusto, Marina Passeri, Patrizia Sperti, Isabella Nardone, Sium Wolde Sellasie, Simona Zaccaria, Lucia Longo, Pietro Lo Deserto, Stefano Amendola, Luigi Uccioli

Background: Resistance to thyroid hormone is a rare syndrome characterized by peripheral resistance to thyroid hormones. It is caused by genetic dysfunction of thyroid receptor genes, with Thyroid hormone Receptor-beta (TRβ) being the most prevalent. Affected patients show high thyroid hormone levels and non-suppressed Thyroid-stimulating Hormone (TSH). Syndrome manifestations vary from hyperthyroidism to hypothyroidism depending on the specific mutation.

Case presentation: We, herein, describe the case of a 24-year-old female with a diagnosis of resistance to thyroid hormone from the age of 7. The main symptoms the patients complained about were headaches, palpitations, hyperidrosis, and frequent evacuations with severe underweight. The patient's blood test showed high FT3 and FT4 levels with a non-suppressed TSH. We performed a disease complications screening that revealed mild osteoporosis and normal cardiac activity (the patient was already treated with bisoprolol).

Conclusion: This case illustrates symptoms and complications of resistance to thyroid hormone syndrome, a rare and misdiagnosed condition. In this case report, we describe and explain longterm disease symptoms and their management. The long-term history of our patient's disease adds a more comprehensive evaluation of the syndrome and its consequences, contributing to new insights into the resistance to thyroid hormone syndrome and shedding light on personalized management of its manifestations.

背景:甲状腺激素抵抗是一种罕见的综合征,其特征是外周对甲状腺激素的抵抗。它是由甲状腺受体基因的遗传功能障碍引起的,其中以甲状腺激素受体-β(TRβ)最为常见。患者表现为甲状腺激素水平高,促甲状腺激素(TSH)不受抑制。根据特定突变,综合征表现从甲状腺功能亢进到甲状腺功能减退不等:患者主诉的主要症状是头痛、心悸、多汗、频繁排便和体重严重不足。患者的血液检查显示 FT3 和 FT4 水平较高,TSH 不受抑制。我们进行了疾病并发症筛查,结果显示患者有轻度骨质疏松症,心脏活动正常(患者已接受比索洛尔治疗):本病例说明了甲状腺激素抵抗综合征的症状和并发症,这是一种罕见的误诊病症。在这份病例报告中,我们描述并解释了长期疾病症状及其治疗方法。患者的长期病史增加了对该综合征及其后果的更全面评估,有助于对甲状腺激素抵抗综合征有新的认识,并为其表现的个性化管理提供启示。
{"title":"Thyroid Hormone Resistance: A 17-Year Follow-up Case Report.","authors":"Cristina Giusto, Marina Passeri, Patrizia Sperti, Isabella Nardone, Sium Wolde Sellasie, Simona Zaccaria, Lucia Longo, Pietro Lo Deserto, Stefano Amendola, Luigi Uccioli","doi":"10.2174/0118715303329834240815193640","DOIUrl":"https://doi.org/10.2174/0118715303329834240815193640","url":null,"abstract":"<p><strong>Background: </strong>Resistance to thyroid hormone is a rare syndrome characterized by peripheral resistance to thyroid hormones. It is caused by genetic dysfunction of thyroid receptor genes, with Thyroid hormone Receptor-beta (TRβ) being the most prevalent. Affected patients show high thyroid hormone levels and non-suppressed Thyroid-stimulating Hormone (TSH). Syndrome manifestations vary from hyperthyroidism to hypothyroidism depending on the specific mutation.</p><p><strong>Case presentation: </strong>We, herein, describe the case of a 24-year-old female with a diagnosis of resistance to thyroid hormone from the age of 7. The main symptoms the patients complained about were headaches, palpitations, hyperidrosis, and frequent evacuations with severe underweight. The patient's blood test showed high FT3 and FT4 levels with a non-suppressed TSH. We performed a disease complications screening that revealed mild osteoporosis and normal cardiac activity (the patient was already treated with bisoprolol).</p><p><strong>Conclusion: </strong>This case illustrates symptoms and complications of resistance to thyroid hormone syndrome, a rare and misdiagnosed condition. In this case report, we describe and explain longterm disease symptoms and their management. The long-term history of our patient's disease adds a more comprehensive evaluation of the syndrome and its consequences, contributing to new insights into the resistance to thyroid hormone syndrome and shedding light on personalized management of its manifestations.</p>","PeriodicalId":94316,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142083029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Activation of the Keap1/Nrf2/HO-1 Pathway by "Tianyu" Pairing: Implications for Inflammation and Oxidative Stress in Rheumatoid Arthritis. 天宇 "配对激活 Keap1/Nrf2/HO-1 通路:类风湿性关节炎中的炎症和氧化应激的影响。
Pub Date : 2024-08-26 DOI: 10.2174/0118715303307608240812114651
Lu Tang, Mingquan Li, Songlan Piao, Lianyun Du, Saiyue Qiu, Xin Jiang, Meixiu Luo, Yinghang Wang, Zhi Pan

Objective: The objective of this study was to examine the impact of "Tianyu" Pairing on oxidative stress in the development of Rheumatoid arthritis (RA) and approach its potential mechanism using cell experiments.

Methods: A cell model of RA was developed by stimulating rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) with tumor necrosis factor-α (TNF-α). This model aimed to assess the impact of serum containing Rhodiola rosea-Euonymus alatus drug pair (TYP) on inflammation and oxidative stress in the development of RA, specifically through the Keap1/Nrf2/HO-1 pathway.

Results: The findings from the in vitro experiment demonstrated that the presence of TYP in the serum effectively suppressed the proliferation of RA-FLS induced by TNF-α. Additionally, TYP facilitated the apoptosis of afflicted cells, attenuated the migratory and invasive capabilities of diseased cells, and decreased the levels of Kelch ECH associating protein 1 (Keap1), reactive oxygen species (ROS), glutathione peroxidase (GSH-Px), catalase (CAT), and malondialdehyde (MDA) (p < 0.01). The influence of inflammation and oxidative stress in RA-FLS cells was reduced by increasing the nuclear-cytoplasmic ratio of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) and levels of phosphorylated Nrf2, Heme Oxygenase 1 (HO-1), and Superoxide Dismutase (SOD) (p < 0.01).

Conclusion: TYP can regulate inflammation and oxidative stress in RA-FLS cells by activating the Keap1/Nrf2/HO-1 pathway.

研究目的本研究的目的是通过细胞实验研究 "天喻 "配对对类风湿性关节炎(RA)发病过程中氧化应激的影响及其潜在机制:通过用肿瘤坏死因子-α(TNF-α)刺激类风湿性关节炎成纤维细胞样滑膜细胞(RA-FLS),建立了RA细胞模型。该模型旨在评估含有红景天-玉竹药对(TYP)的血清对RA发病过程中炎症和氧化应激的影响,特别是通过Keap1/Nrf2/HO-1途径的影响:体外实验结果表明,血清中的 TYP 能有效抑制 TNF-α 诱导的 RA-FLS 增殖。此外,TYP 还能促进病变细胞的凋亡,减弱病变细胞的迁移和侵袭能力,降低 Kelch ECH 相关蛋白 1(Keap1)、活性氧(ROS)、谷胱甘肽过氧化物酶(GSH-Px)、过氧化氢酶(CAT)和丙二醛(MDA)的水平(p < 0.01)。通过提高核因子红细胞2相关因子2(Nrf2)的核-胞质比率以及磷酸化Nrf2、血红素氧化酶1(HO-1)和超氧化物歧化酶(SOD)的水平,减轻了炎症和氧化应激对RA-FLS细胞的影响(p < 0.01):结论:TYP可通过激活Keap1/Nrf2/HO-1途径调节RA-FLS细胞的炎症和氧化应激。
{"title":"Activation of the Keap1/Nrf2/HO-1 Pathway by \"Tianyu\" Pairing: Implications for Inflammation and Oxidative Stress in Rheumatoid Arthritis.","authors":"Lu Tang, Mingquan Li, Songlan Piao, Lianyun Du, Saiyue Qiu, Xin Jiang, Meixiu Luo, Yinghang Wang, Zhi Pan","doi":"10.2174/0118715303307608240812114651","DOIUrl":"https://doi.org/10.2174/0118715303307608240812114651","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study was to examine the impact of \"Tianyu\" Pairing on oxidative stress in the development of Rheumatoid arthritis (RA) and approach its potential mechanism using cell experiments.</p><p><strong>Methods: </strong>A cell model of RA was developed by stimulating rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) with tumor necrosis factor-α (TNF-α). This model aimed to assess the impact of serum containing Rhodiola rosea-Euonymus alatus drug pair (TYP) on inflammation and oxidative stress in the development of RA, specifically through the Keap1/Nrf2/HO-1 pathway.</p><p><strong>Results: </strong>The findings from the in vitro experiment demonstrated that the presence of TYP in the serum effectively suppressed the proliferation of RA-FLS induced by TNF-α. Additionally, TYP facilitated the apoptosis of afflicted cells, attenuated the migratory and invasive capabilities of diseased cells, and decreased the levels of Kelch ECH associating protein 1 (Keap1), reactive oxygen species (ROS), glutathione peroxidase (GSH-Px), catalase (CAT), and malondialdehyde (MDA) (p < 0.01). The influence of inflammation and oxidative stress in RA-FLS cells was reduced by increasing the nuclear-cytoplasmic ratio of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) and levels of phosphorylated Nrf2, Heme Oxygenase 1 (HO-1), and Superoxide Dismutase (SOD) (p < 0.01).</p><p><strong>Conclusion: </strong>TYP can regulate inflammation and oxidative stress in RA-FLS cells by activating the Keap1/Nrf2/HO-1 pathway.</p>","PeriodicalId":94316,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142083028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Endocrine, metabolic & immune disorders drug targets
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1